JNJ Surpasses Market Expectations with Record Quarterly Sales

Johnson & Johnson (JNJ) has posted record quarterly results, exceeding market expectations. The company's sales reached $25.3 billion, a 6.6% year-over-year increase and a new quarterly high.

This milestone is significant as it brings JNJ closer to its 2026 target of over $100 billion in annual revenue for the first time in its history. The company has also increased both its current fiscal year sales and adjusted EPS guidance, solidifying its position as a leader in the industry.

The Dividend Aristocrat has consistently demonstrated its commitment to rewarding shareholders through steady payout increases. With this latest achievement, JNJ is poised to continue delivering strong results and meeting investor expectations.